Detalles de la búsqueda
1.
IL-15/IL-15Rα-Fc fusion protein XmAb24306 potentiates activity of CD3 bispecific antibodies through enhancing T cell expansion.
Mol Cancer Ther
; 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38739434
2.
CYT-1 isoform of ErbB4 is an independent prognostic factor in serous ovarian cancer and selectively promotes ovarian cancer cell growth in vitro.
Gynecol Oncol
; 129(1): 179-87, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23313737
3.
IMiDs Augment CD3-Bispecific Antibody-Induced CD8+ T-Cell Cytotoxicity and Expansion by Enhancing IL2 Production.
Mol Cancer Ther
; 22(5): 659-666, 2023 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36822576
4.
Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer.
Breast Cancer Res Treat
; 128(2): 347-56, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20730488
5.
[Targeted cytotoxic drugs emerging for cancer therapy]. / Vasta-aineisiin konjugoidut solunsalpaajat tulossa syövän hoitoon.
Duodecim
; 127(4): 343-9, 2011.
Artículo
en Fi
| MEDLINE | ID: mdl-21442854
6.
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer.
Mol Cancer Ther
; 20(4): 716-725, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33536191
7.
Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody.
JCI Insight
; 5(7)2020 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32271166
8.
Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.
Mol Biol Cell
; 17(1): 67-79, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16251361
9.
CD3 bispecific antibody-induced cytokine release is dispensable for cytotoxic T cell activity.
Sci Transl Med
; 11(508)2019 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31484792
10.
Therapeutic resistance and susceptibility is shaped by cooperative multi-compartment tumor adaptation.
Cell Death Differ
; 26(11): 2416-2429, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30824837
11.
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo properties.
MAbs
; 11(2): 422-433, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30550367
12.
DNA topoisomerase I is a cofactor for c-Jun in the regulation of epidermal growth factor receptor expression and cancer cell proliferation.
Mol Cell Biol
; 25(12): 5040-51, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15923621
13.
IFNγ-induced Chemokines Are Required for CXCR3-mediated T-Cell Recruitment and Antitumor Efficacy of Anti-HER2/CD3 Bispecific Antibody.
Clin Cancer Res
; 24(24): 6447-6458, 2018 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29950350
14.
Relative Target Affinities of T-Cell-Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model.
Mol Cancer Ther
; 17(4): 776-785, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29339550
15.
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3.
Sci Transl Med
; 10(463)2018 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30333240
16.
Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells.
Clin Cancer Res
; 12(13): 4103-11, 2006 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16818711
17.
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells.
Cancer Res
; 65(4): 1384-93, 2005 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15735025
18.
bisFabs: Tools for rapidly screening hybridoma IgGs for their activities as bispecific antibodies.
MAbs
; 9(3): 430-437, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28125314
19.
Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells.
MAbs
; 9(2): 213-230, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27929752
20.
Membrane-Proximal Epitope Facilitates Efficient T Cell Synapse Formation by Anti-FcRH5/CD3 and Is a Requirement for Myeloma Cell Killing.
Cancer Cell
; 31(3): 383-395, 2017 03 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28262555